Wockhardt Limited

BSE: 532300 NSE: WOCKPHARMA
Wockhardt Limited - life sciences in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
CIN L24230MH1999PLC120720 Incorporated 08 July 1999 ROC Mumbai HQ Aurangabad, Maharashtra, India
Active Listed - NSE: WOCKPHARMA · BSE: 532300 Public Limited Company life sciences
Data last updated
Market Cap
₹33,862 Cr
WOCKPHARMA · NSE
Share Price
₹2,077.20
-1.85% today
Revenue
₹3,373 Cr
FY 2025-26 · +7.1% YoY
EBITDA
₹567 Cr
Margin 16.8%
Net Profit
₹284 Cr
FY 2025-26 · +9998.0% YoY
P/E (TTM)
86.2x
P/B 7.0x
ROE
5.8%
ROCE 7.8%
Debt / Equity
0.46
Interest cover 62.6x

About Wockhardt Limited

Data last updated:

Wockhardt Limited is a public limited company based in Aurangabad, Maharashtra, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 08 July 1999, the company has been in operation for over 27 years.

Registered with ROC Mumbai under CIN L24230MH1999PLC120720. Listed on BSE: 532300 and NSE: WOCKPHARMA.

Capital: an authorised share capital of ₹1,125 Cr and a paid-up capital of ₹81.25 Cr. Formerly known as Wockhardt Pharmaceuticals Limited. It is led by directors including Vinesh Kumar Jairath and Zahabiya Habil Khorakiwala.

Last AGM: 08 August 2025. Financial statements filed for year ended 31 March 2025. Office: Wockhardt Research Centre D – 4 M.I.D.C. Chikalthana, Aurangabad, Maharashtra, India – 431006.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹3,373 Cr, a growth of 11.99% compared to the previous year. The net worth stands at ₹4,940 Cr (up 13.48% YoY). Total assets are valued at ₹7,633 Cr (up 12.7% YoY).

The company has a workforce of approximately 2,065 employees as per the latest available data. Its group structure includes 3 subsidiaries.

As per MCA filings, the company has open charges of ₹1,614.65 Cr and satisfied charges of ₹10,105 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wockhardt.com.

Company Details of Wockhardt Limited
CIN L24230MH1999PLC120720
Registration Number 120720
Incorporation Date 08 July 1999
ROC Mumbai
Listing Status Listed (BSE: 532300, NSE: WOCKPHARMA)
Company Status Active
Date of Last AGM 08 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Murtaza Habil Khorakiwala Managing Director Huzaifa Habil Khorakiwala Whole-Time Director Habil Fakhruddin Khorakiwala Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    wockhardt.com
  • Social Media
  • Registered Address
    Wockhardt Research Centre D – 4 M.I.D.C. Chikalthana, Aurangabad, Maharashtra, India – 431006
  • Industry
    Life Sciences, Biotechnology
Company report
Wockhardt Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Wockhardt Limited report

Financials, compliance, directors, charges, ownership and filings for Wockhardt Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Wockhardt

Wockhardt operates primarily in the manufacturing and trade sectors. 2 business activities are registered with the MCA.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
LockedManufacturingLockedChemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
LockedTradeLockedWholesale TradingLocked
Premium access

Detailed business activity records for Wockhardt Limited

Activity codes and each activity's share of turnover are in the company report.

  • Activity group codes
  • Detailed activity codes
  • Turnover contribution

Verified entity values are shown only after access is granted.

Auditor Details of Wockhardt

Wockhardt Limited is audited by B S R & Co. LLP for the financial year 2024.

NameStatusAppointment DateCessation Date
B S R & Co. LLPLockedLockedLocked
Premium access

Complete auditor history for Wockhardt Limited

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Wockhardt Limited

Wockhardt has 9 current directors and 23 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vinesh Kumar Jairath
Also directs: Kirloskar Oil Engines Limited, Kirloskar Industries Limited, Sahyadri Hospitals Private Limited
Director10 Nov 20169 Years 10 MonthsCurrent
Zahabiya Habil Khorakiwala
Also directs: HZ Trading & Services LLP, HNZ Trading & Services LLP, Wockhardt Bionova Limited and 5 more
Director30 Oct 20178 Years 11 MonthsCurrent
Akhilesh Krishna GuptaDirector29 Aug 20206 Years 1 MonthsCurrent
Huzaifa Habil Khorakiwala
Also directs: Amalthea Trading & Services LLP, Helike Trading & Services LLP, Wockhardt Hospitals Limited and 5 more
Whole-Time Director29 Jun 200917 Years 3 MonthsCurrent
Habil Fakhruddin Khorakiwala
Also directs: Lysithea Trading & Services LLP, Amalthea Trading & Services LLP, HZ Trading & Services LLP and 5 more
Whole-Time Director08 Jul 199927 Years 2 MonthsCurrent
Murtaza Habil Khorakiwala
Also directs: Lysithea Trading & Services LLP, Adrastea Trading & Services LLP, Wockhardt Bionova Limited and 5 more
Managing Director29 Jun 200917 Years 3 MonthsCurrent
Showing 6 of 9 current directors. View all directors

Financials of Wockhardt Limited FY 2025-26 filings available

Wockhardt Limited reported revenue of ₹3,373 Cr (up 11.99% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹3,373 Cr
+12.0% YoY
EBITDA
₹567 Cr
+44.3% YoY
Profit After Tax
₹284 Cr
+704.4% YoY
Net Worth
₹4,940 Cr
+13.5% YoY
Total Assets
₹7,633 Cr
+12.7% YoY
Total Debt
₹2,233 Cr
+10.5% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue3,3733,0122,7982,6513,2302,7082,844
Revenue growth+7.1%-5.6%-2.5%-8.7%+6.9%+6.9%-24.4%
EBITDA56739325.00(193)115(205)119
EBITDA margin+16.8%+13.1%+0.9%-7.3%+3.6%-7.6%+4.2%
Profit before tax238(16.00)(420)(624)(411)417(247)
Net profit284(47.00)(405)(270)(75.69)828(164)
Net profit margin+8.4%-1.6%-14.5%-10.2%-2.3%+30.6%-5.8%
EPS (₹)13.15(2.90)(30.06)(38.82)(16.94)62.36(6.25)
Balance sheet
Total assets7,6336,7736,1185,9506,5846,5176,685
Net worth4,9404,3533,3593,3543,8493,3762,672
Total debt2,2332,0212,3562,1842,1982,6743,582
Cash & bank250191529124406292268
Net working capital1,2497165775079581,196967
Cash flow
Cash from operations390(22.00)219153413(287)649
Cash from investing(231)(780)(138)(118)(204)1,471(147)
Cash from financing(54.00)409334(315)(71.00)(1,171)(680)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue929965888782738743721809
Revenue growth (YoY)+25.9%+29.9%+23.2%-3.3%-0.1%+6.1%+2.9%+7.4%
Other income31.0067.0025.0021.0020.0015.008.009.00
EBITDA192225167178(25.00)64.00128110
EBITDA margin+20.7%+23.3%+18.8%+22.8%-3.4%+8.6%+17.8%+13.6%
Depreciation55.0053.0065.0053.0056.0053.0055.0055.00
Interest52.0050.0060.0055.0048.0048.0060.0073.00
Profit before tax11618967.0091.00(109)(22.00)21.00(9.00)
Tax9.0025.006.009.00(1.00)23.001.007.00
Net profit10716461.0082.00(108)(45.00)20.00(16.00)
EPS (₹)6.5510.223.614.81(5.53)(1.57)0.91(1.47)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,7391,4021,1541,0721,372987890
Revenue growth+10.9%-8.5%-2.7%+7.6%-9.2%+23.8%-36.8%
EBITDA517300(50.00)(165)222(280)(133)
EBITDA margin+29.7%+21.4%-4.3%-15.4%+16.2%-28.4%-15.0%
Profit before tax317(12.00)(422)(513)(184)362(389)
Net profit292(12.00)(408)(231)(140)735(326)
Net profit margin+16.8%-0.9%-35.4%-21.6%-10.2%+74.5%-36.6%
EPS (₹)19.57(0.74)(27.40)(32.36)(9.72)53.91(20.87)
Balance sheet
Total assets5,0884,5893,9603,7924,2683,7173,880
Net worth3,0842,7631,7961,7532,2121,606995
Total debt1,9641,7962,1362,0132,0242,0782,370
Cash & bank10711348637.00207138157
Net working capital1,031749760535858661727
Cash flow
Cash from operations241(14.00)18871.00(93.00)(563)222
Cash from investing(193)(900)(75.00)(3.00)(244)1,014(16.15)
Cash from financing(7.00)486346(236)430(480)(274)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue561516430380413355325370
Revenue growth (YoY)+35.8%+45.4%+32.3%+2.7%+17.3%0.0%+12.9%+42.3%
Other income33.0090.0027.0030.0025.0014.006.0011.00
Total expenses403355327267282249263321
EBITDA15816110311313110662.0049.00
EBITDA margin+28.2%+31.2%+24.0%+29.7%+31.7%+29.9%+19.1%+13.2%
Depreciation41.0043.0052.0045.0046.0040.0042.0043.00
Interest43.0041.0050.0044.0041.0040.0048.0053.00
Profit before tax10716728.0054.0069.0040.00(22.00)(36.00)
Tax0.000.000.000.000.000.000.000.00

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 03 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue929965888782738743721809
Revenue growth (YoY)+25.9%+29.9%+23.2%-3.3%-0.1%+6.1%+2.9%+7.4%
Other income31.0067.0025.0021.0020.0015.008.009.00
EBITDA192225167178(25.00)64.00128110
EBITDA margin+20.7%+23.3%+18.8%+22.8%-3.4%+8.6%+17.8%+13.6%
Depreciation55.0053.0065.0053.0056.0053.0055.0055.00
Interest52.0050.0060.0055.0048.0048.0060.0073.00
Profit before tax11618967.0091.00(109)(22.00)21.00(9.00)
Tax9.0025.006.009.00(1.00)23.001.007.00
Net profit10716461.0082.00(108)(45.00)20.00(16.00)
EPS (₹)6.5510.223.614.81(5.53)(1.57)0.91(1.47)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue3,3733,0122,7982,6513,2302,7082,844
Revenue growth+7.1%-5.6%-2.5%-8.7%+6.9%+6.9%-24.4%
Other income11162.0083.0012220.001,117133
Total expenses2,8062,6192,7732,8443,1152,9132,725
Employee cost725651629637749763743
EBITDA56739325.00(193)115(205)119
EBITDA margin+16.8%+13.1%+0.9%-7.3%+3.6%-7.6%+4.2%
Depreciation227217223251247246224
Interest213254305302299249276
Profit before tax238(16.00)(420)(624)(411)417(247)
Tax39.0041.0052.00(3.00)(132)(271)(204)
Net profit284(47.00)(405)(270)(75.69)828(164)
Net profit margin+8.4%-1.6%-14.5%-10.2%-2.3%+30.6%-5.8%
EPS (₹)13.15(2.90)(30.06)(38.82)(16.94)62.36(6.25)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital81.0081.0077.0072.0072.0055.0055.37
Reserves & surplus4,8594,2723,2823,2823,7773,3212,616
Shareholders' funds (net worth)4,9404,3533,3593,3543,8493,3762,672
Minority interest341304303308353383386
Secured loans9985265937647201,0941,805
Unsecured loans1,2351,4951,7631,4201,4781,5801,777
Total debt2,2332,0212,3562,1842,1982,6743,582
Total liabilities7,6336,7736,1185,9506,5846,5176,685
Assets
Gross block6,1645,8145,7215,4356,0185,6555,656
Net block2,7912,7362,8813,0423,4623,3433,502
Capital work in progress2,3792,0331,7221,5391,3421,3791,585
Investments4124220.000.000.000.000.45
Inventories887725640658769799690
Sundry debtors5886616187979189181,243
Cash & bank balances250191529124406292268
Loans & advances469466286629496416229
Total current assets2,1942,0432,0732,2082,5892,4252,430
Total current liabilities9451,3271,4961,7011,6311,2291,462
Net working capital1,2497165775079581,196967
Total assets7,6336,7736,1185,9506,5846,5176,685
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash11250590.00370232219397
Net cash from operating activities390(22.00)219153413(287)649
Net cash from investing activities(231)(780)(138)(118)(204)1,471(147)
Net cash from financing activities(54.00)409334(315)(71.00)(1,171)(680)
Net change in cash105(393)415(280)13813.00(178)
Closing cash250191529124406292268
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+12.0%+7.7%+5.6%-17.9%+19.3%-4.8%-20.2%
EBITDA growth+44.3%+1472.0%+9998.0%-+9998.0%-+9998.0%
PBT growth+9998.0%+96.2%+32.7%-51.8%-+9998.0%+29.6%
Net income growth+9998.0%+88.4%-50.3%-256.3%-+9998.0%+15.8%
Revenue CAGR (3Y)+8.4%-2.3%+1.1%-2.3%-3.2%-11.7%-10.9%
EBITDA CAGR (3Y)-+50.6%----16.8%+110.3%
Profitability & leverage
Net income margin+5.9%-1.9%-16.9%-23.4%-8.6%+25.4%-1.5%
Return on capital employed+7.8%+3.9%-0.9%-0.5%+1.2%-2.9%-1.1%
Return on net worth+5.8%-1.5%-12.3%-9.2%-3.1%+27.5%-5.2%
Debt / equity0.460.570.680.610.671.031.20
Long-term debt / equity0.310.310.230.150.190.390.57
Interest cover62.65144.32-154.04-68.02-226.52-55.21-262.33
Efficiency & per share
Fixed asset turnover0.560.520.500.460.550.480.53
Inventory turnover4.184.414.313.724.123.643.77
Debtors turnover5.404.713.953.093.522.512.26
EPS (₹)13.15(2.90)(30.06)(38.82)(16.94)62.36(6.25)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)304.94268.70218.12232.92267.29306.91241.26
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue561516430380413355325370
Revenue growth (YoY)+35.8%+45.4%+32.3%+2.7%+17.3%0.0%+12.9%+42.3%
Other income33.0090.0027.0030.0025.0014.006.0011.00
Total expenses403355327267282249263321
EBITDA15816110311313110662.0049.00
EBITDA margin+28.2%+31.2%+24.0%+29.7%+31.7%+29.9%+19.1%+13.2%
Depreciation41.0043.0052.0045.0046.0040.0042.0043.00
Interest43.0041.0050.0044.0041.0040.0048.0053.00
Profit before tax10716728.0054.0069.0040.00(22.00)(36.00)
Tax0.000.000.000.000.000.000.000.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,7391,4021,1541,0721,372987890
Revenue growth+10.9%-8.5%-2.7%+7.6%-9.2%+23.8%-36.8%
Other income16255.0041.0067.0038.001,026138
Total expenses1,2221,1021,2041,2371,1501,2671,023
Employee cost313262247240261293325
EBITDA517300(50.00)(165)222(280)(133)
EBITDA margin+29.7%+21.4%-4.3%-15.4%+16.2%-28.4%-15.0%
Depreciation186168176186171184173
Interest176199237229273200220
Profit before tax317(12.00)(422)(513)(184)362(389)
Tax0.000.000.00(47.00)(44.00)(231)(158)
Net profit292(12.00)(408)(231)(140)735(326)
Net profit margin+16.8%-0.9%-35.4%-21.6%-10.2%+74.5%-36.6%
EPS (₹)19.57(0.74)(27.40)(32.36)(9.72)53.91(20.87)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital81.0081.0077.0072.0072.0055.0055.37
Reserves & surplus3,0032,6821,7191,6812,1401,551939
Shareholders' funds (net worth)3,0842,7631,7961,7532,2121,606995
Secured loans6662216818309211,1391,084
Unsecured loans1,2981,5751,4551,1831,1039391,286
Total debt1,9641,7962,1362,0132,0242,0782,370
Total liabilities5,0884,5893,9603,7924,2683,7173,880
Assets
Gross block3,6043,3583,3743,3833,4123,1053,315
Net block1,3521,2761,4491,6251,8281,6842,044
Capital work in progress1,3971,260833823825716305
Investments709719297297297297297
Inventories533426321363387348315
Sundry debtors8466125665511,292955940
Cash & bank balances10711348637.00207138157
Loans & advances392417295524502398194
Total current assets1,8781,5681,6681,4752,3881,8391,607
Total current liabilities8478199089401,5301,178880
Net working capital1,031749760535858661727
Total assets5,0884,5893,9603,7924,2683,7173,880
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash35.004634.0017279.00108177
Net cash from operating activities241(14.00)18871.00(93.00)(563)222
Net cash from investing activities(193)(900)(75.00)(3.00)(244)1,014(16.15)
Net cash from financing activities(7.00)486346(236)430(480)(274)
Net change in cash41.00(428)459(168)93.00(29.00)(68.61)
Closing cash10711348637.00207138157
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+24.0%+21.5%+7.7%-21.9%+39.0%+10.9%-42.9%
EBITDA growth+72.3%+9998.0%+69.7%-+9998.0%-110.3%-114.9%
PBT growth+9998.0%+97.2%+17.7%-178.8%-+9998.0%-71.8%
Net income growth+9998.0%+97.1%-76.6%-65.0%-+9998.0%-297.7%
Revenue CAGR (3Y)+17.5%+0.7%+5.4%+6.4%-4.1%-26.4%-27.1%
EBITDA CAGR (3Y)-+10.6%-43.7%+7.4%---
Profitability & leverage
Net income margin+18.2%-0.9%-36.6%-43.5%-10.2%+60.1%-26.0%
Return on capital employed+9.6%0.0%0.0%0.0%0.0%-7.4%0.0%
Return on net worth+9.9%0.0%0.0%0.0%0.0%+56.5%0.0%
Debt / equity0.640.861.171.021.071.711.64
Long-term debt / equity0.430.500.420.210.300.610.67
Interest cover53.17150.76-104.87-65.24535.29-43.10-71.83
Efficiency & per share
Fixed asset turnover0.500.420.340.320.420.310.29
Inventory turnover3.633.753.372.863.732.982.60
Debtors turnover2.392.382.071.161.221.040.92
EPS (₹)19.57(0.74)(27.40)(32.36)(9.72)53.91(20.87)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)190.37170.56116.62121.74153.61146.0089.82
Want more history and ratios?
You're viewing the latest exchange-filed financials for Wockhardt Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Wockhardt Limited

Shareholding for the quarter ended Sep 2026: promoters hold 49.10%, foreign institutional investors hold 7.20%, domestic institutional investors hold 9.30% and retail and other public shareholders hold 34.40%.

Promoters: 49.10%DII (Domestic Institutional): 9.30%FII (Foreign Institutional): 7.20%Retail & Others: 34.40%
Sep 2026
QUARTER
49.10% Promoters
9.30% DII (Domestic Institutional)
7.20% FII (Foreign Institutional)
34.40% Retail & Others
Promoter holding - history
Now 49.10% · Sep 2026High 49.10% · Dec 2025Low 49.10% · Dec 2025
48%48.8%49.5%50.3%51%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 49.10%Mar 2026: 49.10%Jun 2026: 49.10%Sep 2026: 49.10%49.10%49.10%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters49.10%49.10%49.10%49.10%
Public50.90%50.90%50.90%50.90%

Group Structure of Wockhardt Limited

Wockhardt has 3 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

3
Subsidiary companies
Key Subsidiaries
Company NameCINShares Held
Wockhardt Infrastructure DevelopmentU24230MH1991PLC060162-
Wockhardt Biologics LimitedU24299MH2021PLC363201-
Wockhardt Medicines LimitedU74999MH2019PLC322942-

Showing major subsidiaries. Total: 3.

Charges & Borrowings of Wockhardt

Open charges
₹1,614.65 Cr
Satisfied charges
₹10,105 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹1,001.65 Cr
Others₹613.00 Cr
Latest charge details
DateLenderAmountStatus
30 Mar 2026Sbicap Trustee Company Limited₹50 CrOpen
23 Mar 2026Others₹350 CrOpen
28 Jun 2025Others₹200 CrOpen
29 Dec 2023Others₹50 CrOpen
29 Jul 2021Others₹13 CrOpen

Total charge records: 55 View all charges

Employees and EPFO Compliance at Wockhardt

Wockhardt Limited has a workforce of 2,065 employees as of Apr 06, 2024.

Employee count
2,065
Active EPFO establishments
4
Employee growth
-13.96%
Premium access

Employee and EPFO history for Wockhardt Limited

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Wockhardt

Premium access

GST registrations and filing compliance for Wockhardt Limited

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Wockhardt

Premium access

Credit ratings, litigation, and regulatory alerts for Wockhardt Limited

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Wockhardt

Premium access

MSME payment history for Wockhardt Limited

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Wockhardt

Premium access

Corporate group structure for Wockhardt Limited

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Wockhardt

Premium access

MCA filings and documents for Wockhardt Limited

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Wockhardt

Charges
30 Mar 2026
A charge with Sbicap Trustee Company Limited amounted to Rs. 50.00 Cr with Charge ID 101276799 was registered on 30 Mar 2026.
Charges
23 Mar 2026
A charge with Others amounted to Rs. 350.00 Cr with Charge ID 101261751 was registered on 23 Mar 2026.
Charges
02 Dec 2025
A charge with Others of Rs. 200.00 Cr registered on 28 Jun 2025 with Charge ID 101116191 was modified on 02 Dec 2025.
Directors
03 Nov 2025
Om Prakash Bhatt was appointed as a Additional Director on 03 Nov 2025 & has been associated with this company since 11 months 1 day.
Charges
21 Aug 2025
A charge with Others of Rs. 50.00 Cr registered on 29 Dec 2023 with Charge ID 100841754 was modified on 21 Aug 2025.
Activity
08 Aug 2025
Wockhardt Limited last Annual general meeting of members was held on 08 Aug 2025 as per latest MCA records.

Recent News on Wockhardt

Frequently Asked Questions about Wockhardt Limited

Wockhardt is an active public limited company in the life sciences sector based in Aurangabad, Maharashtra, India. It was incorporated on 08 July 1999 (27+ years old) and is registered under CIN L24230MH1999PLC120720. Listed on BSE: 532300 and NSE: WOCKPHARMA. The company has 2,065 employees.

Wockhardt reported revenue of ₹3,373 Cr for FY 2025-26 (up 11.99% YoY) based on consolidated financials.

The current directors of Wockhardt are:

The primary industry of Wockhardt is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.

Yes. Wockhardt is listed on both BSE (code: 532300) and NSE (symbol: WOCKPHARMA).

Wockhardt can be reached at the registered office: Wockhardt Research Centre D – 4 M.I.D.C. Chikalthana, Aurangabad, Maharashtra, India – 431006, or through the website wockhardt.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available